Release Date: 30/04/14 09:55 Summary: 3rd Quarter Activity and Cashflow Report - 31 March 2014 Price Sensitive: Yes Download Document 1.66MB Download
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market